BRIEF-Sanofi, Regeneron's high cholesterol drug Praluent gets EMA nod

* EU Medicines Agency recommends approval of high cholesterol drug Praluent from Sanofi SA/Regeneron Pharmaceuticals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.